SCHEMBL4625281

SCHEMBL4625281

COc1ccc(/C=C/C(=N)NCc2ccccc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.55
▸ ALDH1A1 P00352 2/20 0.55
▸ MEN1 O00255 1/20 0.55
▸ KMT2A Q03164 1/20 0.55
▸ PLAAT3 P53816 1/20 0.55
▸ PLAAT5 Q96KN8 1/20 0.55
▸ PLAAT2 Q9NWW9 1/20 0.55
▸ PLAAT4 Q9UL19 1/20 0.55
▸ SNCA P37840 1/20 0.55
▸ MAOB P27338 2/20 0.53
▸ MAPT P10636 1/20 0.53
▸ THRB P10828 1/20 0.53
▸ APP P05067 1/20 0.52
▸ GSK3B P49841 2/20 0.51
▸ NPC1 O15118 2/20 0.51
▸ HDAC3 O15379 1/20 0.51
▸ HDAC1 Q13547 1/20 0.51
▸ HDAC2 Q92769 1/20 0.51
▸ HDAC8 Q9BY41 1/20 0.51
▸ CYP3A4 P08684 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4626728 0.99 LMNA (0.54) LMNAALDH1A1MEN1KMT2APLAAT3
SCHEMBL4626265 0.94 RAB9A (0.56) LMNAALDH1A1MEN1KMT2APLAAT3
Hydrochloric Acid SCHEMBL4627120 0.93 RAB9A (0.58) LMNAALDH1A1MEN1KMT2APLAAT3
SCHEMBL4626376 0.85 GRIN1 (0.56) LMNAALDH1A1MAOBHDAC3HDAC1
SCHEMBL4625918 0.85 KDM4E (0.55) LMNAALDH1A1MEN1KMT2AMAOB
SCHEMBL5082489 0.85 MMP1 (0.65) LMNAALDH1A1MEN1KMT2APLAAT3
SCHEMBL3029548 0.85 MMP1 (0.65) LMNAALDH1A1MEN1KMT2APLAAT3
Hydrochloric Acid SCHEMBL4626360 0.84 KDM4E (0.54) LMNAALDH1A1MEN1KMT2AMAOB
Hydrochloric Acid SCHEMBL7041561 0.84 GRIN1 (0.55) LMNAALDH1A1MAOBHDAC3HDAC1
Hydrochloric Acid SCHEMBL4627931 0.84 GRIN1 (0.55) LMNAALDH1A1MAOBHDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1296940-B1 AMIDINE DERIVATIVES AS SELECTIVE ANTAGONISTS OF NMDA RECEPTORS MERCK SHARP & DOHME (GB) 2008-07-02 — — EP claimed
US-20030119871-A1 Amidine derivatives as selective antagonists of ndma receptors CURTIS NEIL ROY (GB) 2003-06-26 — — US claimed
EP-1296940-B1 AMIDINE DERIVATIVES AS SELECTIVE ANTAGONISTS OF NMDA RECEPTORS MERCK SHARP & DOHME (GB) 2008-07-02 — — EP disclosed
US-20030119871-A1 Amidine derivatives as selective antagonists of ndma receptors CURTIS NEIL ROY (GB) 2003-06-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030119871-A1 Amidine derivatives as selective antagonists of ndma receptors GRIN1, GRIN2A, GRM1 LMNA 1855/4885ALDH1A1 4432/4885MEN1 3385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback